U.S., July 11 -- ClinicalTrials.gov registry received information related to the study (NCT07695337) titled 'Continuous Infusion Versus Intermittent Bolus Hydrocortisone in Septic Shock' on July 06.
Brief Summary: Septic shock is a life-threatening condition in which infection causes dangerously low blood pressure and organ dysfunction despite fluid resuscitation and vasopressor treatment. Hydrocortisone is commonly used in patients with septic shock who continue to require vasopressors. However, it is uncertain whether hydrocortisone should be administered as a continuous intravenous infusion or as intermittent intravenous bolus doses.
This randomized controlled trial evaluates whether continuous intravenous hydrocortisone infusion impro...